CHLA Scientist Awarded $1.2M to Study Drug Resistance in Leukemia
December 20, 2018
Acute Lymphoblastic Leukemia (ALL) is the most prevalent childhood cancer, with more than 3,000 new cases reported each year. The majority of patients with ALL survive following chemotherapy